Increased intraglomerular pressure is an important hemodynamic determinant of glomerulosclerosis and can be modeled in vitro by exposing mesangial cells to cyclic mechanical strain. A previous study showed that RhoA mediates strain-induced production of fibronectin; herein is investigated the role of caveolae in RhoA activation. Cyclodextrin and filipin, agents that disrupt caveolae, abrogated strain-induced RhoA activation in mesangial cells. Caveolin-1 (cav-1), the defining protein of caveolae, was Y14 phosphorylated by strain, and this was inhibited by PP1, showing Src dependence. Strain also induced c-SrcY416 phosphorylation and hence activation. Strain increased RhoA association with cav-1, which was blocked by PP1. Cyclodextrin and filipin inhibited the strain-induced RhoA/cav-1 association, indicating dependence on caveolar structural integrity. Restoration of caveolae by coincubation of cyclodextrin with cholesterol rescued both RhoA activation and RhoA/cav-1 association in response to strain. Sucrose gradient detected a significant portion of RhoA in caveolae, with Src located exclusively in these domains. Finally, in cells that were infected with retrovirus that encodes the nonphosphorylatable cav-1 Y14A, RhoA/cav-1 association, RhoA activation, and fibronectin secretion in response to strain were abrogated. It is concluded that strain-induced RhoA activation depends on the integrity of caveolae and on physical association of cav-1 and RhoA. The phosphorylation of cav-1 at Y14 by Src kinases is required for this to occur. These studies define a novel function for cav-1 and caveolae as positive effectors of RhoA activation. Targeting caveolae thus may provide a new therapeutic option for glomerular sclerosis that is associated with elevated intraglomerular pressure.
levated glomerular capillary pressure (Pgc) is an important hemodynamic determinant of progression in chronic renal diseases of diverse causes (1) . Interventions that normalize Pgc, such as interruption of the reninangiotensin system, reduce glomerular injury and matrix expansion (2, 3) . The mechanisms that translate glomerular capillary hypertension to glomerular injury, however, have not been elucidated fully.
Increased Pgc transmits to mesangial cells (MC), which provide architectural support for the glomerular capillary tuft, as mechanical strain (4) . MC that are subjected to cyclic strain/ relaxation increase extracellular matrix protein synthesis (5) (6) (7) . We have shown that activation of the small GTPase RhoA and its downstream mediator Rho-kinase are important mediators of strain-induced production of the matrix protein fibronectin in MC (8) . Recently, RhoA was localized to the plasma membrane microdomains caveolae in cardiomyocytes, astrocytes, and endothelial cells (9 -12) .
Caveolae are 50-to 100-nm plasma membrane omega-shaped invaginations that function in endocytosis and have been shown to play an important role in cell signaling (13) . Caveolae are found in most cell types, including MC (14, 15) . They are defined by the presence of caveolin, a 21-to 24-kD integral membrane protein that is essential for their formation (14) . Three isoforms of caveolin exist, with only caveolin-1 (cav-1) and -2 showing wide coexpression (16) . MC express cav-1 (15) . In cells that lack cav-1 either naturally or through genetic manipulation or downregulation, caveolae are not present (16 -18) . Conversely, expression of cav-1 can induce the de novo formation of caveolae in these cells (17) . The role of cav-2 is less clear, possibly functioning to stabilize the cav-1 protein (19) .
Caveolin is a transmembrane noncatalytic protein with both N-and C-termini facing the cytoplasm (14) . A growing and varied list of signaling molecules have been identified as residing in caveolae, and interactions with caveolin are believed to sequester these proteins within caveolae and modulate or suppress their catalytic activities (16, 20) . Signaling proteins clustering within these microdomains may facilitate rapid interaction and thereby signal transduction (14, 21, 22) . Both Src family tyrosine kinases and Rho family members have been found in caveolae (16, 20) . Cav-1 phosphorylation on tyrosine 14 (Y14) in the N terminus first was identified in v-Src-transformed cells (23) . The functional consequences of this are not fully known, but phosphorylation at this site has been demonstrated in response to various stimuli, including osmotic and shear stress and growth factor receptor activation (24 -27) .
Mechanical stress in vascular smooth muscle and endothelial cells has been shown to increase the number of caveolae, and activation of Akt and the mitogen-activated protein kinase signaling cascades requires these domains to be intact (28 -30) .
Most recently, static stretch in cardiomyocytes was shown to alter the caveolar localization of RhoA (9) . We therefore studied the function of caveolae in RhoA activation by stretch in MC and sought to characterize the role of an interaction with cav-1 in this system.
Materials and Methods

Cell Culture
Sprague-Dawley primary rat MC were cultured in DMEM supplemented with 20% FCS (Invitrogen, Carlsbad, CA), streptomycin (100 g/ml), and penicillin (100 units/ml) at 37°C in 95% air, 5% CO 2 . Experiments were carried out using cells between passages 6 and 15. 293T cells were cultured in DMEM supplemented with 10% serum.
Application of Strain/Relaxation
MC were plated onto six-well plates with flexible bottoms coated with bovine type I collagen (Flexcell International Corp., Hillsborough, NC). After achieving confluence, cells were rendered quiescent by incubation for 24 h in serum-free medium. Plates were exposed to continuous cycles of strain/relaxation that were generated by a cyclic vacuum that was produced by a computer-driven system (Flexercell 4000; Flexcell International Corp.), with each cycle consisting 0.5 s of strain (10%) and 0.5 s of relaxation for a total of 60 cycles/min. Pharmacologic inhibitors were added at the indicated concentrations and times before stretch: Cyclodextrin (Calbiochem, San Diego, CA), 5 mM for 60 min; filipin III (Sigma, St. Louis, MO), 2.5 g/ml for 10 min; and cholesterol (Sigma), 15 g/ml for 60 min, PP1 (Biomol, Plymouth Meeting, PA), 10 M for 30 min.
Protein Extraction and Western Immunoblotting
Cells were lysed and protein was extracted as we have published (8) . Briefly, cells were lysed in buffer that contained 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerophosphate, 2 mM dithiothreitol, 1 mM sodium vanadate, 1 mM PMSF, 1 g/ml leupeptin, and 20 g/ml aprotinin. Lysates were centrifuged at 4°C and 14,000 rpm for 10 min to pellet cell debris. Supernatant that contained soluble cell proteins (50 g) was separated on SDS-PAGE, and Western blotting performed as we have described (8) . Antibodies used included polyclonal phospho-cav-1Y14 (1:1000; BD Biosciences, Franklin Lake, NJ), monoclonal cav-1 (1:1000; BD Biosciences), monoclonal RhoA (1:500; Santa Cruz Biotechnology, Santa Cruz, CA), polyclonal phospho-SrcY416 (1:500; Cell Signaling), polyclonal Src (1:1000; Cell Signaling, Danvers, MA), and monoclonal FLAG (10 g/ml; Sigma; M2).
For assessment of secreted fibronectin, MC were stretched for 24 h. Conditioned medium was collected and centrifuged (4000 rpm for 5 min) to pellet debris, and 10 g of protein was separated on a 7.5% gel. Membranes were probed with monoclonal anti-fibronectin (1:5000; BD Biosciences).
Purification of Caveolar Membrane Fractions
Cells were washed in cold PBS, lysed in MES-buffered saline (MBS; 25 mM Mes [pH 6.5] and 150 mM NaCl) with 1% Triton X-100 and protease/phosphatase inhibitors, then solubilized by 10 passes through a 25-G needle and sonicated for 20 s each at settings 3, 4, and 5 on ice. Samples were equalized for protein; mixed with equal volume of 90% sucrose in MBS; overlain with 35, 30, 25, and 5% sucrose in MBS; and centrifuged at 100,000 ϫ g for 16 to 20 h at 4°C. A light-scattering band representing the caveolar fraction occurred at the 5 to 25% interface. From the top of each gradient, 12 equal fractions were collected, and protein was concentrated by centrifugation (33,000 ϫ g, 45 min) and separated on a 15% gel (18, 31) . Fractions 2 to 5 correspond to caveolae, as confirmed by immunoblotting for cav-1 and exclusion of paxillin (1:1000; BD Biosciences).
RhoA Pull-Down Assay
This was performed as described previously (8) . Briefly, cells were lysed in hypertonic buffer, and GTP-bound RhoA was immunoprecipi- Figure 1 . Strain-induced RhoA activation depends on caveolae. (A) Lysate from serum-deprived, resting mesangial cells (MC) was separated by sucrose gradient density centrifugation into 12 fractions as outlined in Materials and Methods. Caveolar fractions 2 to 4 were identified by the presence of caveolin-1 (cav-1) and exclusion of paxillin. RhoA was found to be present in both caveolar fractions and in the higher density noncaveolar cytosolic fractions. (B) MC were stretched for 1 min in the presence or absence of caveolar disrupting agents cyclodextrin (5 mM, 1 h) or filipin (2.5 g/ml, 10 min). GTP-loaded (active) RhoA was measured using a pull-down assay, and RhoA from total cellular lysate was immunoblotted to ensure baseline equality across conditions. Both agents prevented stretch-induced RhoA activation. Co-incubation with cholesterol (15 g/ml) reversed the effects of cyclodextrin. *P Ͻ 0.01 versus control;
# P Ͻ 0.001 versus stretch; n ϭ 3.
tated from cleared lysate with 30 g of glutathione-agarose-bound GST-tagged rhotekin RhoA binding domain (purified from bacterial lysate). Beads were washed, and the immunoprecipitate was resolved on 15% SDS-PAGE. Membranes were probed with anti-RhoA antibody. Lysate (40 g) also was probed for RhoA to ensure equality across conditions.
Immunoprecipitation
Cells were lysed with lysis buffer that included 60 mM N-octylglucopyranoside. After clarification, equal amounts of lysate were incubated overnight with 2 g of monoclonal RhoA antibody, rotating at 4°C, followed by 25 l of protein G-agarose slurry for 1.5h at 4°C. Immunoprecipitates were washed extensively, resuspended in 2ϫ sample buffer, boiled, and analyzed by immunoblotting.
Fluorescence Microscopy
This was performed as described previously (32) . Briefly, MC were fixed with formaldehyde, permeabilized with Triton X-100, blocked with BSA/donkey serum, and incubated with monoclonal RhoA (1:50; Santa Cruz Biotechnology) and polyclonal cav-1 (1:50; BD Biosciences). After fluorochrome-conjugated secondary antibody incubation and mounting, images were acquired with a fluorescence microscope (Zeiss, Oberkochen, Germany).
Infection of MC
Rat cav-1 was amplified from MC cDNA and inserted into the retroviral vector pLHCX with an N-terminal FLAG. Using this as template, Y14 was mutated to alanine. MC were infected with empty vector or FLAG-cav-1 Y14A as described previously (8, 33) . In brief, competent virus that was capable of single infection was generated using the vesicular stomatitis virus system (Stratagene, La Jolla, CA), and MC passages 5 to 12 were exposed to virus that was concentrated by centrifugation in the presence of polybrene. Seventy-two hours after infection, a 2-wk antibiotic selection period was begun. Experiments were performed using a population of pooled, stably infected MC.
Statistical Analyses
Densitometry was obtained using Scion Image (National Institutes of Health, Bethesda, MD), and analysis was performed using one-way ANOVA with Tukey Honestly Significant Difference (HSD) for post hoc analysis (SPSS 11.0 for Windows; SPSS, Chicago, IL). P Ͻ 0.05 (twotailed) was considered significant. Data are represented as the mean Ϯ SEM. Experiments were repeated multiple times.
Results
Stretch-Induced Activation of RhoA Depends on Caveolae
RhoA has been shown to reside in caveolae in various cell types (9, 11, 12) . We therefore first performed sucrose gradient density centrifugation to confirm that RhoA also resides in these microdomains in MC. Figure 1A shows that in MC in their basal state, RhoA is present in both the lighter caveolar fractions (2 to 4, confirmed by immunoblotting with cav-1) and in noncaveolar cytoplasmic lysate (heavier fractions 9 to 12). Distribution of RhoA Figure 2 . RhoA and cav-1 association increases with strain, and this depends on caveolar integrity. (A) MC were stretched for the times indicated, and RhoA was immunoprecipitated from total cellular lysate. Immunoprecipitates then were probed for cav-1, and equal RhoA pull-down was confirmed with immunoblotting for RhoA. Stretch significantly increased RhoA association with cav-1, with a peak at 1 min (*P Ͻ 0.03 versus control, n ϭ 4). (B) Immunofluorescence for RhoA (red) and cav-1 (green) was performed after MC were stretched for 1 min. Stretch induces RhoA membrane accumulation and co-localization with cav-1 (arrows). (C) MC were incubated with cyclodextrin with or without cholesterol, or with filipin alone, and stretched for 1 min. RhoA was immunoprecipitated from total cell lysate. The stretch-induced association between RhoA and cav-1 was abrogated by the caveolar disruptors, and the effects of cyclodextrin were reversed by provision of excess cholesterol. *P Ͻ 0.05 versus other groups; n ϭ 3.
into these different fractions may provide subpopulations that are more responsive to particular stimuli.
Because caveolae have been found to mediate the activation of mitogen-activated protein kinase pathways in response to shear stress in endothelial cells (34) and RhoA localized to caveolae in MC, we studied the effects of caveolar disruption on RhoA activation. We previously determined that maximal early activation of RhoA by stretch in MC occurs at 1 min (8) . We used the membrane-impermeable cholesterol-binding agent cyclodextrin, which depletes cell surface cholesterol, and the membrane-permeable agent filipin III to perturb the formation of caveolae. Both have been shown to abolish almost completely the presence of caveolae by electron microscopy (35, 36) . We observed that both cyclodextrin and filipin prevented the stretch-induced activation of RhoA ( Figure 1B ). Because caveolar disruption that is mediated by cyclodextrin resides in its ability to chelate extracellular cholesterol, thereby making it unavailable for incorporation into caveolae (13), we tested whether the effect of cyclodextrin was reversible by co-incubation with excess cholesterol. As seen in Figure 1B , cholesterol reversed the effects of cyclodextrin on RhoA activation. These data indicate that stretch-induced RhoA activation depends on the structural integrity of caveolae in MC. Figure 3 . Cav-1 is phosphorylated on tyrosine-14 (Y14) by Src kinases in response to stretch. (A) MC were stretched for the indicated times, and cav-1 Y14 phosphorylation was assessed by immunoblotting with a site-and phosphorylation-specific antibody. Stretch increased the Y14 phosphorylation of cav-1 by 1 min. *P Ͻ 0.05 versus control; n ϭ 6. (B) Src activation was similarly assessed with an antibody that targeted the autophosphorylation site Y416, which is known to be correlated with Src activation. Src also was activated by 1 min of stretch. *P Ͻ 0.01 versus control; n ϭ 6. (C) MC were incubated with the Src kinase inhibitor PP1 (10 m, 30 min) and stretched for 1 min. Lysates were probed for cav-1 phospho-Y14. Phosphorylation on this residue was blocked by the Src inhibitor. *P Ͻ 0.01 versus control; # P Ͻ 0.03 versus stretch; n ϭ 6. Lower panels confirm that stretch-induced Src phosphorylation at 1 min was blocked effectively by PP1. (D) Lysate from serum-deprived resting MC was separated into 12 fractions by sucrose gradient centrifugation, and the location of Src was assessed. Src is seen to localize to caveolae (fractions 2 to 5). (E) MC were incubated with cyclodextrin or filipin or with cyclodextrin with cholesterol and stretched for 1 min. Src activation was assessed by immunoblotting for phospho-Y416. The stretch-induced activation of Src kinase completely depended on intact caveolar structures. *P Ͻ 0.04 versus control;
RhoA Association with Caveolin-1 Increases with Strain and Depends on Caveolar Integrity
Interaction with cav-1 largely enables protein compartmentalization to caveolae (20) . RhoA has been found to interact directly with cav-1 in endothelial cells (11) . We therefore sought an association between RhoA and cav-1 in MC and determined how mechanical stretch might influence this. Figure 2A shows that at baseline, no significant association between RhoA and cav-1 was observed in MC, as determined by immunoprecipitation of RhoA and immunoblotting for cav-1. However, stretch led to a significantly increased association between RhoA and cav-1, with maximal association occurring at the time of maximal RhoA activation (1 min). This interaction also was observed with immunofluorescence microscopy as a yellow-orange band in some membrane areas ( Figure 2B ). Disruption of caveolae with either cyclodextrin or filipin prevented this association ( Figure 2C) , with cholesterol again reversing the effects of cyclodextrin. These data demonstrate that an intact caveolar structure is indispensable for association between these two proteins.
Stretch Leads to Cav-1 Phosphorylation
Phosphorylation of cav-1 on Y14 has been shown to increase with some growth factors as well as osmotic, oxidative, and shear stresses (24, 25, 27, 37) . The phosphorylation status of cav-1 may modulate its interaction with other proteins (35, 38) . We therefore studied phosphorylation at Y14 in response to mechanical stretch.
Stretch induced phosphorylation at cav-1 Y14 in a timedependent manner, with a significant increase occurring by 1 min of stretch ( Figure 3A) . Because Src kinases are the only known cav-1 Y14 kinases (23), we assessed the effect of stretch on Src activation in our system. Stretch increased the autophosphorylation of Y416 on Src, indicative of increased Src activity, with kinetics paralleling cav-1 Y14 phosphorylation ( Figure  3B ). We then sought to confirm that cav-1 Y14 phosphorylation was mediated by Src. Figure 3C shows that the Src family kinase inhibitor PP1 prevented cav-1 Y14 phosphorylation at 1 min of stretch. We confirmed the effectiveness of PP1 on inhibition of Src activation at 1 min of stretch by observing ablation of Y416 phosphorylation with the inhibitor.
Src and its related kinases have been localized to caveolae in numerous cell types (20) . Using sucrose gradient density separation, we confirmed that Src is found exclusively in caveolar fractions in MC ( Figure 3D ). Because RhoA activation and its association with cav-1 depended on intact caveolar structures, we assessed the effects of caveolar disruption on Src activation. Figure 3E shows that Src activation is abrogated by both cyclodextrin and filipin, and the effects of cyclodextrin are reversed by cholesterol co-incubation. These data indicate that Src resides in caveolae in MC, is activated by stretch, and phosphorylates cav-1 at Y14.
Src Is Required for Stretch-Induced RhoA Activation
Given that Src-mediated cav-1 Y14 phosphorylation occurs in response to stretch, we studied whether stretch-induced cav-1/RhoA association and RhoA activation were sensitive to PP1. In Figure 4A , MC were stretched for 1 min in the presence or absence of PP1, and RhoA/cav-1 association was assessed by co-immunoprecipitation. The stretch-induced association of these two proteins was prevented by Src inhibition. Furthermore, PP1 also fully prevented stretch-induced RhoA activation at its maximal time of induction (1 min), as shown in Figure 4B . These results show that Src is required for RhoA/cav-1 association as well as for RhoA activation in MC and further suggest that cav-1 Y14 phosphorylation is important for these events to occur.
Cav-1 Y14A Prevents Stretch-Induced RhoA Activation and Fibronectin Secretion
To establish definitively that phosphorylation on Y14 of cav-1 is required for stretch-induced RhoA activation, we constructed a cav-1 Y14A mutant in which the tyrosine is replaced by the nonphosphorylatable residue alanine. This was tagged with the epitope FLAG and inserted into the retroviral vector pLHCX. We first confirmed that this mutant could not be phosphorylated. Empty vector, wild-type cav-1, and cav-1 Y14A were transfected into 293T cells, which do not contain caveolin or caveolae. Cells that were grown in 10% serum-supplemented medium showed phosphorylation of cav-1 Y14. This was not detected in the Y14A cells ( Figure 5A ). Figure 5B shows stable overexpression of cav-1 Y14A after selection of a pooled pop- Figure 3 . Continued. ulation of MC. We then assessed the effects of this mutant on the association of cav-1 and RhoA. In Figure 5C , MC that were infected with empty vector or cav-1 Y14A were stretched for 1 min, and association of cav-1 and RhoA was sought as in previous experiments by immunoprecipitation of RhoA. It is clear that cav-1 Y14A not only fails to associate with RhoA but also effectively prevents the association of RhoA with endogenous cav-1, thereby acting as a dominant negative construct in this system. If this association is important in RhoA activation, as suggested by our studies with PP1 ( Figure 4A) , then RhoA activation also should be inhibited by this mutant. Figure 5D shows that cav-1 Y14A also effectively prevented the activation of RhoA by stretch. These studies demonstrate the importance of cav-1 Y14 phosphorylation and the association of cav-1 and RhoA for stretch-induced RhoA activation in MC.
In previous work, we showed that RhoA activation mediates stretch-induced upregulation and secretion of the matrix protein fibronectin (8) . Because cav-1 is required for RhoA activation by stretch, we examined its role in fibronectin production. MC that were infected with empty vector or cav-1 Y14A were stretched for 24 h, and conditioned media (10 g) were collected for immunoblotting. Cells were plated in equal numbers before stretch and counted after stretch. No significant cell death was observed either with stretch or with Y14A. As seen in Figure 6 , stretch induced fibronectin secretion into the medium in MC that were infected with empty vector. This response was abrogated in MC that expressed the mutant cav-1.
Discussion
Our results demonstrate a necessity for caveolae and, importantly, for cav-1 in stretch-induced RhoA activation in MC. Specifically, we found that (1) stretch leads to a dynamic physical association between cav-1 and RhoA, (2) the integrity of the caveolar structure is important in allowing cav-1/RhoA association and RhoA activation, and (3) cav-1/RhoA association and RhoA activation depend on the Src-mediated phosphorylation of Y14 on cav-1. A schematic summary is shown in Figure 7 . These define a novel function for cav-1 and caveolae as positive effectors of RhoA activation.
Mechanical shear stress stimulated the tyrosine phosphorylation of caveolar-localized proteins in isolated plasma membranes, with resultant extracellular signal-regulated kinase (Erk) activation (34) . Stretch-induced tyrosine phosphorylation also was seen in caveolae (by sucrose gradient fractionation) in rat portal veins, and cyclodextrin prevented cellular hypertrophy, DNA synthesis, and endothelin-1 mediated Erk activation (39) . It is of interest that angiotensin II-mediated Erk activation did not require caveolae in this system, suggesting that caveolae may impart stimulus specificity to downstream signaling pathways. Indeed, in sheared endothelial cells, the activation of Erk but not c-Jun N-terminal kinase depended on intact caveolae (28, 29) . Recently, the activation of RhoA and Rac1 in cardiomyocytes by static stretch also was found to depend on intact caveolae (9) . Our data showing the dependence of RhoA activation on the integrity of caveolae further identify these microdomains as important transducers of the mechanical signal.
Caveolar localization of signaling molecules might provide a Figure 4 . RhoA activation and association with cav-1 in response to stretch is Src-dependent. (A) MC were stretched for 1 min after treatment with the Src inhibitor PP1, and RhoA was immunoprecipitated from total cell lysate. Immunoblotting for cav-1 showed that Src inhibition completely prevented the stretch-induced association between RhoA and cav-1. *P Ͻ 0.01 versus control and PP1; # P ϭ 0.02 versus stretch; n ϭ 5. (B) MC were treated with PP1 before stretch for 1 min, and RhoA activity was assessed by a pull-down assay of GTP-bound RhoA. Src inhibition completely prevented the activation of RhoA by stretch. *P Ͻ 0.001 versus control;
# P Ͻ 0.001 versus stretch; n ϭ 4.
compartmental basis for their regulated activation. Both RhoA and Src have been identified as residents of caveolae in various cell types (11), and we also have confirmed this in MC. Cav-1, through its scaffolding domain (amino acids 82 to 101), has been shown to interact with many of these proteins, including RhoA and Src (20) . This interaction most commonly is inhibitory and maintains kinases such as Erk in an inactive state, with stimulus-induced release from cav-1 required for activation (21, 40) . In some cases, however, a stimulatory role for this interaction has been shown, as in the case of insulin receptor signaling (41) . Our studies provide another such example, in which cav-1 and RhoA interaction occurred with stretch and was required for subsequent RhoA activation.
How caveolar localization and cav-1 interaction might facilitate RhoA activation remains to be elucidated. Three types of Rho regulators exist: guanine nucleotide exchange factors facilitate GDP for GTP exchange, GTPase-activating proteins increase the intrinsic GTP hydrolytic rate, and guanine dissociation inhibitors (GDI) help maintain Rho proteins in the inactive state (42, 43) . It is possible that caveolae contain and concentrate factors that assist in RhoA activation and exclude those that prevent it and that cav-1 provides a scaffold on which to bring these proteins together. Activated forms of other small GTPases Rac1 and Cdc42 also have been shown to interact directly with cav-1 (44) . Indeed, the inhibitory Rho GDI are excluded from caveolae in unstimulated fibroblasts and cardiomyocytes (9,12). The nonphosphorylatable mutant cav-1 Y14A was constructed by PCR, placed into the retroviral vector pLHCX-FLAG, and tested in 293T cells. Because these cells do not possess endogenous cav-1, they also were transfected with the wild-type construct. Cells were grown in full serum, and phosphorylation of cav-1 at Y14 was detectable only in cells that were transfected with the wild-type construct. (B) MC were infected with cav-1 Y14A and selected, and a pooled population of cells were assessed for expression of the construct by immunoblotting for both the epitope FLAG and cav-1. (C) MC that expressed either empty vector pLHCX or cav-1 Y14A were stretched for 1 min, and RhoA was immunoprecipitated from total cell lysate. The stretch-induced association between RhoA and cav-1 was blocked by the nonphosphorylatable mutant. *P Ͻ 0.01 versus control; n ϭ 3. (D) MC were stretched as in C, and RhoA activity was assessed by pull-down assay for GTP-bound RhoA. Cav-1 Y14A completely blocked stretch-induced RhoA activation. *P Ͻ 0.03 versus control; n ϭ 3.
In statically stretched cardiomyocytes, the departure of RhoA from caveolae correlated with a decrease in its activation, suggesting that these microdomains may provide a favorable environment for RhoA activation by excluding inhibitory regulators (9) . However, neither the caveolar presence of other Rho regulatory proteins nor the distribution of Rho GDI in response to any stimuli has been assessed. A single report is contradictory, showing that ␣5␤1 integrin ligation and relocation to caveolae in endothelial cells led to RhoA inactivation by activating the inhibitory p190Rho GTPase-activating proteins in the cytoplasm, although the time point examined was significantly longer than in our study (45) .
To date, Src family kinases are the only known kinases to effect cav-1 tyrosine phosphorylation, and this occurs exclusively at residue Y14 (46, 47) . Our data show that stretch induces the Src-mediated phosphorylation of cav-1 on Y14 and that this is necessary for stretch-induced RhoA activation. Phosphorylation on Y-14 has been observed in response to insulin and EGF receptor (EGFR) activation, as well as in other systems that are characteristic of mechanical stress, including hyperosmotic stress in NIH3T3 cells and shear in endothelial cells (24, 25, 27, 31, 48) . EGFR transactivation also leads to cav-1 phospho-Y14 in response to endothelin-1 in MC and angiotensin II in smooth muscle cells (35, 49) . In the latter, phosphorylation parallels cav-1 dissociation from the EGFR, suggesting that this might induce release of proteins from inhibitory cav-1 binding.
As we have shown, however, cav-1 Y14 phosphorylation also might facilitate interaction of other proteins with cav-1, enabling their activation. Indeed, it has been postulated that once phosphorylated, Y14 may provide a docking site for other proteins. This is thought to occur through SH2-domain interactions, as with Grb7. This then may link caveolae to other proteins, often in areas of focal adhesions, and facilitate downstream signaling (31, 50) . Indeed, cav-1 phospho-Y14 has been found to co-immunoprecipitate with the focal adhesion protein paxillin after angiotensin II stimulation, whereas unphosphorylated cav-1 did not shown focal adhesion preference (31, 35) . It also has been shown that cav-1 Y14 phosphorylation recruits cytosolic C-terminal Src kinase, a negative regulator of Src kinases, to caveolae through the SH2 domain on C-terminal Src kinase. This might serve to control the duration of Src signaling (26, 47) . It is not known how RhoA might interact with phospho-Y14 cav-1 because it does not possess an SH2 domain. However, other proteins, such as TRAF2, without such a phosphotyrosine binding domain also have been found to associate preferentially with the phosphorylated form of cav-1 (47) . It is possible that other intermediary proteins that contain these domains may assist in this association. Recently, it also was observed that EGF-induced cav-1 Y14 phosphorylation induced the formation of caveolae in epithelial cells, with a reduction in caveolar number exhibited by cells that harbor the nonphosphorylatable mutant cav-1 Y14F (51). It therefore is possible that, in our cells, maneuvers that decreased the phosphorylation of cav-1 also may have downregulated the total number of caveolae that were available for signal transduction.
Vascular RhoA upregulation was demonstrated recently in several hypertensive rat models (52) , as was cav-1 upregulation in models of both renal and cardiovascular disease (15, 53, 54) . Our data showing the importance of caveolae and cav-1 in Figure 7 . Diagram showing our proposed schematic for stretchinduced activation of RhoA in MC. Mechanical stress leads to the activation of Src, which phosphorylates cav-1 on Y14. This requires an intact caveolar microenvironment. Cav-1 Y14 phosphorylation is necessary for subsequent association with RhoA, and this association enables RhoA activation by stretch. Our previous work showed that RhoA activation mediates the stretch-induced upregulation and secretion of the matrix protein fibronectin (8) , and here we show that cav-1 phosphorylation on Y14 is necessary for this to occur. Figure 6 . Cav-1 Y14A prevents stretch-induced fibronectin secretion. MC that expressed either empty vector pLHCX or cav-1 Y14A were stretched for 24 h, after which conditioned medium was assessed for fibronectin by immunoblotting. Cav-1 Y14A prevented the increase in fibronectin secretion in response to stretch. *P Ͻ 0.001 pLHCX stretch versus all others; n ϭ 4.
transmitting mechanical stress signals provide further information for elucidating the role of these microdomains in disease. Having also shown that cav-1 is required for stretch-induced secretion of the matrix protein fibronectin, these findings suggest that upstream targeting of caveolae may provide a potential therapeutic target for chronic kidney disease marked by intraglomerular hypertension.
